We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Evgen Pharma Plc | LSE:EVG | London | Ordinary Share | GB00BSVYN304 | ORD 0.25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.875 | 0.85 | 0.90 | 0.875 | 0.875 | 0.875 | 116,116 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 422k | -4.04M | -0.0147 | -0.59 | 2.39M |
TIDMEVG
Evgen Pharma PLC
14 May 2018
For immediate release 14 May 2018
RNS REACH
Evgen Pharma plc
("Evgen Pharma" or "the Company")
Upcoming Investor Presentations
Evgen Pharma (AIM: EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, is pleased to announce that Dr Stephen Franklin, the Company's CEO, will present at a series of upcoming investor evenings.
The presentation will focus on the Phase II trials of SFX-01, the Company's lead product, in the treatment of breast cancer and subarachnoid haemorrhage, a type of stroke.
Investors and shareholders wishing to register for the investor presentations may do so through the links provided below.
16 May 2018 - ShareSoc Growth Company Seminar, London
Time: The presentation will start at 5.30pm followed by a buffet and refreshments.
Location: Link Asset Services, 65 Gresham Street, London, EC2V 7NQ.
Link to register: https://www.sharesoc.org/events/sharesoc-growth-company-seminar-in-london-16-may-2018/
17 May 2018 - Proactive Investors Healthcare, London
Time: The presentation will start at 6.00pm followed by drinks and canapés.
Location: Chesterfield Mayfair Hotel, 35 Charles Street, London, W1J 5EB.
Link to register: http://www.proactiveinvestors.co.uk/register/event_details/142
19 June 2018 - ShareSoc Growth Company Seminar, Manchester
Time: The presentation will start at 5.30pm followed by a buffet and refreshments.
Location: Kuits Solicitors, 7(th) Floor, Blackfriars House, Manchester, M3 2JA.
Link to register: https://www.sharesoc.org/events/sharesoc-growth-company-seminar-in-manchester-19-june-2018/
A copy of the latest investor presentation will be available from 12pm on 15 May 2018 at: http://evgen.com/investors/shareholder-information/
Enquiries:
Evgen Pharma plc c/o +44 (0) 20 7466 5000 Dr Stephen Franklin, CEO Richard Moulson, CFO www.evgen.com Buchanan Mark Court, Sophie Wills, Stephanie Watson +44 (0) 20 7466 5000
Notes for editors:
About Evgen Pharma plc
Evgen Pharma is a clinical stage drug development company focussed on the development of a new class of pharmaceutical; sulforaphane-based compounds for application in oncology and neurology markets. Lead product, SFX-01, is in two Phase II trials, utilising two separate mechanistic targets, with expected read-outs around the end of 2018.
Evgen Pharma commenced operations in January 2008 and has its headquarters at The Colony, Wilmslow, Cheshire, and its registered office is at the Liverpool Science Park, Liverpool. It joined the AIM market of the London Stock Exchange in October 2015 and trades under the ticker symbol EVG.
For further information, please visit: www.evgen.com
For commissioned research on the Company, please visit: http://evgen.com/investors/analyst-coverage/
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAFMGMKDFMGRZM
(END) Dow Jones Newswires
May 14, 2018 02:00 ET (06:00 GMT)
1 Year Evgen Pharma Chart |
1 Month Evgen Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions